Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Schering-Plough Clarinex Has 12.3% New Rx Share As Of Feb. 25

Mar 04 2002

• By The Pink Sheet

Related Content

Schering-Plough Clarinex Gains Indication Parity With Pfizer’s Zyrtec

Feb 18 2002

Schering-Plough Clarinex Launch Strategy Follows Nexium Model

Jan 07 2002

White House Asks For More FDA Candidates As Wood Is Shed

Feb 25 2002

Allegra Growth Expected At 20% Annually; Generic Impact Possible In 2004

Feb 18 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window